Guinea-Bissau vs Mali: Cause of death, by non-communicable diseases, female
Guinea-Bissau
32.7%
in 2021
Mali
32.2%
in 2021
Guinea-Bissau rank
177th
Mali rank
179th
Cause of death, by non-communicable diseases, female over time
- Guinea-Bissau
- Mali
How they compare
Guinea-Bissau currently reports 32.7% against 32.2% in Mali, a difference of 0.5%.
Across all 6 years both countries report, Guinea-Bissau has been ahead every year.
Guinea-Bissau ranks 177th and Mali ranks 179th of 185 countries.
Guinea-Bissau has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.9% | 23.1% | 1.8% | Guinea-Bissau |
| 2010s | 31.8% | 29.7% | 2.1% | Guinea-Bissau |
| 2020s | 33.1% | 32.1% | 1.0% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Guinea-Bissau or Mali?
- Guinea-Bissau, at 32.7% against 32.2% in Mali as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Guinea-Bissau and Mali?
- 0.5%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Mali?
- 6 years are reported by both, from 2000 to 2021.
- How do Guinea-Bissau and Mali rank globally for cause of death, by non-communicable diseases, female?
- Guinea-Bissau ranks 177th and Mali ranks 179th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.